Professor Katharine Van Tassel joins Concordia Law School after serving the Creighton University School of Law as a Professor of Law and the Director of its Health Law Programs. Previously, Professor Van Tassel was the Director of the University of Akron’s Public Health Law & Science Center as well as a Professor of Law and Director of Akron Law School’s Health Law Programs.
Professor Van Tassel clerked for the U.S. District Court before becoming an associate with the international law firm of Squire, Sanders & Dempsey [now Squire, Patton, Boggs] with offices in 22 countries. She began her teaching career in 1997 and has taught Health Law: Quality, Cost and Access, Healthcare Organization and Finance, Government Provision of Healthcare, Bioethics, Public Health Law, Food & Drug Law, Law & Biotechnology, Criminal Law, Criminal Procedure, Civil Procedure, Evidence, and Torts, among other courses.
Professor Van Tassel’s scholarship has appeared in such journals as the University of Chicago Legal Forum, the Pepperdine Law Review, the Cardozo Law Review, the Connecticut Law Review, the Brooklyn Law Review, the University of Cincinnati Law Review and the Seton Hall Law Review. Her work has been cited by the Nevada Supreme Court, the New Mexico Supreme Court and the New Jersey Tax Court, all on issues of first impression. She was the recipient of Akron Law’s 2013 Faculty Scholar of the Year award.
She is the coauthor of the three-volume encyclopedia Food and Drug Administration (4th ed., 2015) which is cited as an authoritative FDA source by the U.S. Supreme Court and numerous circuit and district courts. She is also the co-author on the book Litigating the Nursing Home Case (2nd ed., 2014). She is the Editor of the Health Law Prof Blog and a blogger on Bill of Health, a blog of the Petrie-Flom Center at the Harvard School of Law.
Professor Van Tassel provided expert testimony at the U.S. Commission on Civil Rights hearings on hospital dumping of uninsured patients with mental health disabilities held in Washington, D.C., has served as a Hearing Officer for medical staff peer review proceedings, and has been a consultant for matters involving the abuse and neglect of nursing home residents. She has served as a Special Commissioner on the Cervical Cancer Special Commission of the House of Representatives of the Commonwealth of Massachusetts and as a member of both the Clinical Ethics Review Team and the Institutional Review Board for Experimental Drugs and Devices of the largest hospital system in Western Massachusetts. Recently, she worked as an expert consultant assisting Georgetown University in building the curriculum for its Regulatory Affairs graduate program focusing on drug and device regulation and as senior regulatory counsel for a Washington, D.C. law firm specializing in food and drug, international customs, and intellectual property law.
She is the Co-Chair of the Food & Drug Law Committee of the Administrative Law Section of the American Bar Association and serves on the Executive Board of the BioLaw Section of the American Association of Law Schools. She has also served on the Executive Boards of the Law & Mental Disability and Law, Medicine & Healthcare Sections of the American Association of Law Schools.
- Top Ten on the New Administration’s FDA Agenda, Section of Administrative Law and Regulatory Practice, 2016 ABA Fall Meeting (Georgetown University, 2016).
-The Growing Use of Nanotechnology in Consumer Products: Is Nanotech the New Asbestos?, University of Maryland School of Law (October, 2016).
- Leadership Issues in Hospital Quality Improvement, Children’s Hospital and Medical Center, Leadership Experience Accelerator Program (Creighton University, 2016).
- The Growing Consumer Exposure to Nanotechnology in Everyday Products: Regulating Innovative Technologies in Light of Lessons from the Past by Creating a “Public Health Product Safety Net,” Center for Health Policy and Ethics, Creighton University (March, 2016).
- The Growing Consumer Exposure to Nanotechnology in Everyday Products: Regulating Innovative Technologies in Light of Lessons from the Past by Creating a “Public Health Product Safety Net,” Health Law Section, Nebraska Bar Association (2015).
- Terminating the Physician-Patient Relationship, provided for the physicians at Children’s Hospital and Medical Center, Leadership Experience Accelerator Program (LEAP) (2015).
- Ebola and the Law, Annual Meeting, American Association of Law Schools, Section on Biolaw (Panelist) (Washington, D.C. 2015).
- Evaluating the US Commission on Civil Rights' 2014 Report on the Equal Access to Emergency Treatment Enforcement Under the Emergency Treatment and Labor Act, Annual Meeting, American Association of Law Schools, Section on Law & Mental Disability (Panelist and Organizer)(Washington, DC, 2015)(solicited speakers for panel including the Chair of the U.S. Commission on Civil Rights).
- The Ebola Crisis: Preparation, Response, and Ethics in Summit County and Beyond, Akron Press Club (Akron, Ohio 2014).
- Ebola: Facts, Myths and Implications, Public Health Law & Science Center, the International Association of Emergency Managers (IAEM), the Center for Emergency Management and Homeland Security Policy Research Program (Akron, Ohio 2014).
- The Affordable Care Act and the Modernization of EMTALA—Opening the Door to Innovations in Artificial Intelligence Including Diagnostic Software Using Genetics, Epigenetics, Proteomics and the Microbiome, the University of Houston Law Center's 2014 Symposium, America's Future Health Care System: Implications for Health Law, Policy, and Ethics (Houston, TX, upcoming, 2014).
- Harmonizing the Affordable Care Act with the Three Main National Systems for Healthcare Quality Improvement: The Tort, Licensure and Hospital Peer Review Systems, Annual Hadassah Lecture (Akron, Ohio 2013).
- Supreme Court Review: Updates on the Legal Decision of the 2013 Term, Constitution Week (Akron, Ohio, 2013).
- First Amendment and FDA Regulation of Off-Label Promotion of Drugs by Manufacturers, Section of Administrative Law and Regulatory Practice, 2013 ABA Fall Meeting (Georgetown, VA., 2013).
- Regulating Uncertainty: Animating the Public Health Safety Net to Capture Consumer Products that Use Innovative Technologies and Biotechnologies including Nanotechnologies, Genetically Modified Food and Cloning to Create Lab Grown Meat, Northeast Ohio Faculty Colloquium (Twinsburg, Ohio, April, 2013) (presentations given by senior faculty from the Case Western Reserve, Akron and Cleveland State Law Schools on works-in-progress).
- Navigating the Practice of Law in the Wake of Ethics 20/20 - Globalization, New Technologies, and What it Means to be a Lawyer in These Uncertain Times, The Joseph G. Miller and William C. Becker Center for Professional Responsibility (Akron, Ohio, April 5, 2013) (Moderator).
- Regulating Uncertainty: Animating the Public Health Safety Net to Capture Consumer Products that Use Innovative Technologies and Biotechnologies, The University of Chicago Legal Forum’s 2013 Symposium Frontiers of Consumer Protection (The University of Chicago, November 2, 2012).
- Overriding the Experts: Executive Rejection of Administrative Agency Expertise, Section of Administrative Law and Regulatory Practice, 2012 ABA Annual Meeting (Chicago, Ill., 2012).
- Issues in Mental Health Law: Genes, Behavior and Litigation: Recent Developments in Law & Psychiatry; Reforming Mental Health Parity Law, Southeastern Association of Law Schools (SEALS) 2011 Annual Conference (Hilton Head Island, July 29, 2011)(Moderator).
- Evaluation of the Statutes and Regulations of the New England States For the Treatment of Tuberculosis In the Context of the Model TB Control Act of 2009 (Boston, MA, March, 2009)(presentation to the Centers for Disease Control and the Consortium of New England State Departments of Public Health and Departments of Epidemiology to Expand TB Control and Prevention).
- Debunking ‘Junk DNA’ - A Public Health Case for the Post-Market Surveillance of Biotech Foods, Annual Conference on Law, Ethics & the Life Sciences (University of Louisville, Brandeis School of Law, 2007).
- Testimony, Biotechnology Issues, Massachusetts Legislators’ Biotechnology Caucus (2007).
- Civil Jury Practice in the District Court: Massachusetts Tort Law For Trial Court Judges, Annual Conference of the Massachusetts District Court and the Massachusetts Trial Court’s Judicial Institute (Williams College, 2006).
- Ethical Issues in Genetic Testing, Annual Massachusetts Medical Association OB/GYN Seminar (Springfield, MA, 2005).
- Ethical and Legal Issues in Extraction of Sperm In Conjunction with Diagnosis of Brain Death, Annual Ethics Service Conference (Franklin Medical Center, Springfield, MA 2005).
- Current Legal Issues in Pre-implantation Embryonic Genetic Testing, Annual Massachusetts Medical Association OB/GYN Seminar (Springfield, MA 2005).
- Product Liability for Biotech Foods, Conference on Product Liability for FDA Regulated Products, Food and Drug Law Institute (Washington, D.C, 2005).
- The Uninsured and The Under Insured: Is A Single Payer System the Solution?, Western Massachusetts Senior Action Council in conjunction with Western Massachusetts Jobs With Justice (Springfield, MA, 2004).
-Ethical and Legal Issues in The Post Mortem Extraction of Sperm, Ethics Grand Rounds (Bay State Medical Center, Springfield, MA, 2004).
-The Basics of Handling Medical Malpractice Cases, Health Law Section of the Massachusetts Bar Association (Springfield, MA, 2002).
Van Tassel, K., Modernizing the Emergency Medical Treatment & Labor Act to Harmonize with the Affordable Care Act to Improve Equality, Quality and Cost of Emergency Care, 15 Hous. J. L. & Health Pol'y 133-39 (2015)(invited article for the University of Houston Law Center's 2014 Symposium, America's Future Health Care System: Implications for Health Law, Policy, and Ethics).
Van Tassel, K, Intellectual Property and Public Health—A White Paper, 7 Akron J. Intell. Prop. 1 (2014) (workshop paper with Ryan Vacca, James Ming Chen, Jay Dratler, Thomas Folsom, Timothy S. Hall, Yaniv Heled, Frank A. Pasquale, Elizabeth Reilly, Jeffrey Samuels, Katherine Strandburg, Kara W. Swanson and Andrew W. Torrance).
Van Tassel, K., Regulating in Uncertainty: Animating the Public Health Product Safety Net to Capture Consumer Products Regulated by the FDA that Use Innovative Technologies, Including Nanotechnologies, Genetic Modification, Cloning, and Lab Grown Meat, 2013 U. Chi. Legal F. 101-156 (2013) (invited article for the University of Chicago Legal Forum’s 2013 Symposium Frontiers of Consumer Protection).
Van Tassel, K., Using Clinical Practice Guidelines and Knowledge Translation Theory to Cure the Negative Impact of the Hospital Peer Review Hearing System on Health Care Quality, Cost, and Access, 40 Pepperdine L. Rev. 911-975 (2013).
Van Tassel, K., Harmonizing the Affordable Care Act with the Three Main National Systems for Healthcare Quality Improvement: The Tort, Licensure and Hospital Peer Review Systems, 78 Brook. L. Rev. 1-41 (2013).
Van Tassel, K., Blacklisted: The Constitutionality of the Federal System for Publishing Reports of 'Bad Doctors' in the National Practitioner Data Bank, 33 Cardozo L. Rev. 101-65 (2012).
Van Tassel, K, Goldman, R., The Growing Consumer Exposure to Nanotechnology in Everyday Products: Regulating Innovative Technologies in Light of Lessons from the Past, 44 Conn. L. Rev. 481-530 (2012).
Van Tassel, K., Slaying the Hydra: The History of Quack Medicine, the Obesity Epidemic and the FDA’s Battle to Regulate Dietary Supplements, 6 Indiana Health L. J. 204-50 (2009).
Van Tassel, K., Genetically Modified Food, Risk Assessment and Scientific Uncertainty Principles: Does the New Understanding of the Networked Gene Trigger The Need For Post-Market Surveillance to Protect Public Health? 15 B.U. J. Science & Tech. Law 220-251 (2009).
Van Tassel, K., Hospital Peer Review Standards and Due Process: Moving From Tort Theories To Contract Principles Based on Clinical Practice Guidelines, 36 Seton Hall L. Rev.1179-1256 (2006).
Van Tassel, K., The Introduction of Biotech Foods to the Tort System: Creating a New Duty To Identify, 72 U. Cinn. L. Rev. 1645-1705 (2004).